Home >  Medicine MDTV >  Medicine Shorts >  Journal Club: Thought...

Journal Club: Thought Leaders Dr Vipul Yagnik ,Executive Editor & Dr Sunny Duttagupta Illuminate the GJMPBU Stage

By - Dr. Nandita Mohan
Published On 2025-07-22 11:30 GMT   |   Update On 2025-07-23 06:22 GMT
Advertisement

In this episode of Journal Club, we shine a spotlight on the Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU)-a multidisciplinary open-access journal published by Scientific Scholar that recently achieved a massive 175% growth in its Journal Citation Reports (JCR) score, rising from 0.4 to 1.1 as per the Clarivate Analytics JCR 2025 report.

We were joined by two esteemed guests:

Advertisement

🔹 Dr. Vipul Yagnik, Executive Editor of GJMPBU and Professor at the Department of Surgery, Banas Medical College and Research Institute, Gujarat, India

🔹 Dr. Sunny Duttagupta, Director of Publishing at Scientific Scholar

The video highlgihts the personal and professional journey of Dr. Yagnik from author to Executive Editor with emphasis on the editorial strategies behind GJMPBU’s extraordinary growth in JCR rankings. Insights from Dr. Duttagupta on the power of consistency in academic publishing. They also explain the role of Medical Dialogues in boosting visibility and readership of the published research, giving advice for new journals and editors looking to grow with Scientific Scholar.

GJMPBU is committed to publishing high-quality research across biomedicine, surgery, and pharmacology. This milestone not only marks a triumph for the journal but also serves as a model for persistence and innovation in scholarly publishing.

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Can Taking 4,000 Steps Just Once a Week Lower the Risk of Death and Heart Disease? Study Provides Clarity

Long-term Exercise Keeps Immune System Younger and Sharper: Study Finds

EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress

DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings

Rare Disease Show - Episode 26: Understanding Pfeiffer Syndrome ft Dr. Roshan Daniel

Tirzepatide proves to be more effective than semaglutide- Results of Surmount 5 Trial

Risk of long COVID in Children May be Twice as High After a Second Infection: Study Reveals

What's Putting India at Risk for Diabetes and Obesity? ICMR Study Reveals the Hidden Dietary Culprit